- Senior Investigator, Section for Translational Research on Retinal and Macular Degeneration
Paul Sieving received his M.D. from the University of Illinois in 1978 and trained in ophthalmology at that institution between 1978 and 1982. He earned a Ph.D. in bioengineering from the University of Illinois in 1981. He was a faculty member at the University of Michigan Medical School for 17 years and moved to NIH in 2001. He combines laboratory research with clinical patient studies of genetic retinal neurodegenerative diseases. He is a member of the Institute of Medicine and currently serves as director of the National Eye Institute.
- (2018). Investigation of the effect of dietary docosahexaenoic acid (DHA) supplementation on macular function in subjects with autosomal recessive Stargardt macular dystrophy. OPHTHALMIC GENETICS. 39(4), 477-486.
- (2018). Mutation in the intracellular chloride channel CLCC1 associated with autosomal recessive retinitis pigmentosa. PLoS Genetics. 14(8),
- (2018). Neuroethics for the National Institutes of Health BRAIN Initiative. JOURNAL OF NEUROSCIENCE. 38(50), 10583-10585.
- (2018). Optical Coherence Tomography Minimum Intensity as an Objective Measure for the Detection of Hydroxychloroquine Toxicity. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 59(5), 1953-1963.
- (2018). Retinal AAV8-RS1 Gene Therapy for X-Linked Retinoschisis: Initial Findings from a Phase I/IIa Trial by Intravitreal Delivery. MOLECULAR THERAPY. 26(9), 2282-2294.